斯基恩腺腺癌:借鉴前列腺癌经验评估与管理罕见恶性肿瘤
本文探讨女性斯基恩腺腺癌(组织学与免疫组化类似前列腺癌)能否采用前列腺癌的评估与管理工具。通过一例病例应用血清PSA动力学、3D多参数MRI、氟环洛芬F-18 PET及雄激素剥夺治疗(ADT),发现3D MP MRI可明确原发灶解剖,氟环洛芬F-18 PET显著改善分期并促使盆腔淋巴结清扫,ADT对PSA动力学产生显著影响。结论认为尽管该病罕见,但可借鉴前列腺癌工具进行管理。
要点
- 3D多参数MRI可清晰显示斯基恩腺腺癌原发灶解剖。
- 氟环洛芬F-18 PET可改善分期,可能影响淋巴结清扫决策。
- ADT可显著影响PSA动力学,即使绝经后女性睾酮正常。
核心结论
- 斯基恩腺腺癌虽罕见,但可采用前列腺癌的评估与管理工具使患者获益。
研究设计与样本
- 本文为个案报道,描述一例斯基恩腺腺癌患者应用前列腺癌相关工具进行评估与管理。
主要发现
- 3D多参数MRI明确了原发灶解剖。
- 氟环洛芬F-18 PET显著提高了分期能力,促使进行了盆腔淋巴结清扫。
- ADT对PSA动力学产生显著影响,尽管患者睾酮水平处于绝经后女性正常范围。
临床怎么用
- 可借鉴前列腺癌的影像学与核医学工具对斯基恩腺腺癌进行分期评估。
- ADT可考虑用于斯基恩腺腺癌的管理,并监测PSA动力学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine if adenocarcinoma of the Skene's glands in women, which has a histological and immunohistochemical appearance similar to prostate cancer, can be evaluated and managed with the same tools we use for prostate cancer. METHODS: Serum prostate-specific antigen kinetics, 3D multiparametric (MP) magnetic resonance imaging (MRI), fluciclovine F-18 positron emission tomography (PET), and androgen deprivation therapy (ADT) were employed in a case of Skene's gland adenocarcinoma. RESULTS: The 3D MP MRI clarified the anatomy of the primary lesion and fluciclovine F-18 PET significantly improved our ability to stage the tumor prompting pelvic lymph node dissection that may have otherwise not been performed. ADT resulted in a significant impact on prostate-specific antigen kinetics despite the patient having a testosterone level in the normal range for a postmenopausal woman. CONCLUSION: Despite the rarity of Skene's gland adenocarcinoma, we can employ many of the tools at our disposal for the evaluation and management of prostate cancer to benefit the women found to have this malignancy.
引用
- Kaufman ME, Miller DT, Ullah A, et al. Skene's Gland Adenocarcinoma: Borrowing From Prostate Cancer Experience for the Evaluation and Management of a Rare Malignancy. Urology. 2020. PMID: 32504685. doi:10.1016/j.urology.2020.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。